When GPs Can Prescribe Mounjaro: the NHS Rollout, Private Routes and What Changes in 2027

Step 1: Check whether your GP practice is actually participating

The new GP contract (QOF 2026/27) allows (but does not compel) practices to prescribe tirzepatide for weight management. That distinction matters. Across England, uptake is patchy: some practices signed up on day one; others are waiting to see how demand develops, or lack the clinical bandwidth to run the required wrap-around support sessions. The quickest check takes under a minute: call or message your surgery and ask directly whether they are offering Mounjaro prescribing under the new contract. Many practices have a dedicated admin response for this now, so you won't need to book an appointment just to find out.

Scotland, Wales and Northern Ireland run their own commissioning arrangements, so NHS criteria and availability differ outside England. NHS prescribing of Mounjaro is covered in more detail for each nation, but as a general rule the thresholds and timelines described in this page apply to England specifically.

NICE's guidance on tirzepatide (TA1026) underpins the NHS rollout and sets out the eligibility thresholds that practices must apply.

Step 2: Understand the eligibility thresholds as they stand

The NHS is rolling Mounjaro out in phases, tied to how many weight-related conditions a patient has alongside their BMI. The first cohort (people with a BMI of 40 or above plus four or more of five specified conditions) became eligible in June 2025. Those five conditions are: high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease and type 2 diabetes.

A second cohort opened on 23 June 2026: adults with a BMI of 35–39.9 plus four or more of those same conditions. A third phase, covering BMI 40 or above with three conditions, is expected from around March 2027. For people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean backgrounds, the BMI thresholds are reduced by 2.5 kg/m² throughout. You can check where your BMI sits using the NHS BMI calculator.

Even if your numbers fit, GP prescribing comes with a non-negotiable condition: you must enrol in a structured wrap-around programme covering diet, physical activity and behaviour change. Treatment isn't simply handed over, it runs alongside that support from the start.

Step 3: Know what happens if your practice isn't ready, or you don't qualify yet

Many people who read this page fall into a gap: their BMI and health picture would plausibly qualify them for Mounjaro, but their practice isn't participating, or they have three conditions rather than four, or they simply don't want to wait until 2027. That gap is exactly where a private prescription route becomes relevant.

Private prescribing of Mounjaro has been legal throughout, it sits outside the NHS rollout entirely. If you're wondering whether your GP can prescribe Mounjaro through a private route, our dedicated guide explains exactly what GPs are and aren't permitted to do, since any GPhC-registered prescriber can issue a private prescription for tirzepatide to any adult who meets the licensed criteria: a BMI of 30 or above, or 27 or above with at least one weight-related condition. The private eligibility bar is lower than the current NHS one because it reflects the medicine's full licensed population rather than NHS prioritisation tiers.

Through a regulated online pharmacy such as ours, the process runs without a GP referral or a waiting list, a prescriber reviews your consultation the same day, and getting Mounjaro through a private route means treatment can begin once you're assessed as suitable. The full Mounjaro overview explains the licensed eligibility criteria, how titration works and what the clinical trial evidence shows.

Step 4: Understand the private route before you commit

If you're considering a private prescription, knowing what a legitimate service looks like matters. Any regulated prescriber (whether a GP or an independent prescriber working in a pharmacy setting) must assess you before issuing a prescription. That means reviewing your medical history, current medicines, BMI and relevant conditions. Photo-ID checks, live weight verification and GP notification in line with GPhC guidance are part of responsible practice.

Pricing is a common question on this topic. Private Mounjaro costs more per month than NHS supply (which, for qualifying patients, is dispensed at the standard prescription charge). The cost of treatment through our service includes the consultation, prescription, and free next-working-day delivery, one price, no hidden fees. For a more detailed breakdown of how private costs compare, the weight-loss treatment overview covers the full picture.

What it shouldn't include is a shortcut past the clinical assessment. If a seller offers Mounjaro without asking you any health questions, that is a regulatory red flag regardless of price. Counterfeit pens seized in the UK have contained incorrect or dangerous substances, the MHRA has a reporting tool for suspect sellers and products.

Our frequently asked questions cover the most common queries about eligibility and process. If you'd like to speak to someone directly, the contact page has our support details.

If you're ready to find out whether you're suitable, check your eligibility through a free consultation, a real prescriber reviews it the same day.